Literature DB >> 21212569

Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease.

Tomonari Okada1, Toshiyuki Nakao, Hiroshi Matsumoto, Yume Nagaoka, Ryo Tomaru, Hideaki Iwasawa, Toshikazu Wada.   

Abstract

BACKGROUND: Glycated albumin (GA), which is an alternative glycemic marker, is influenced by factors associated with albumin turnover, and it is not clear whether proteinuria influences GA values in diabetic patients with chronic kidney disease (CKD).
METHODS: We enrolled 94 diabetic patients with CKD stages 3 to 5. GA, glycated hemoglobin, and urinary protein excretion (UP) levels were consecutively obtained in each patient. The correlations between GA and UP and those between changes in GA and UP were examined.
RESULTS: There was a significant correlation between GA and UP in all cases (r=-0.46, p<0.0001), however no significant correlation was found in cases with UP of 0-3.49 g/day (r=0.01). GA values in cases with UP ≥3.5 g/day were significantly lower than those in cases with UP <3.5 g/day [UP ≥3.5 g/day and serum albumin (Alb) ≤3 g/dL; 12.0 ± 1.3%, UP ≥3.5 g/day and Alb >3 g/dL; 17.8 ± 4.3%, 0≥ UP <3.5 g/day; 21.2 ± 4.2%], while no significant difference in HbA(1c) or glucose levels was found. In cases with a minimum of UP ≥0.5 g/day, no significant correlation was found between the difference in GA and the difference in UP at the point of maximum UP and minimum UP (r=0.04).
CONCLUSION: Nephrotic-range proteinuria decreases GA values independent of the glycemic state, while non-nephrotic range proteinuria has no significant influence on GA values in diabetic CKD patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21212569     DOI: 10.2169/internalmedicine.50.4129

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  18 in total

1.  Influence of albumin leakage on glycated albumin in patients with type 2 diabetes undergoing hemodialysis.

Authors:  Sayo Ueda; Kojiro Nagai; Narushi Yokota; Daisuke Hirose; Hiroaki Mori; Yoshihiko Noma; Toshio Doi; Jun Minakuchi
Journal:  J Artif Organs       Date:  2019-02-25       Impact factor: 1.731

Review 2.  Managing Diabetes and Cardiovascular Risk in Chronic Kidney Disease Patients.

Authors:  Dragana Lovre; Sulay Shah; Aanu Sihota; Vivian A Fonseca
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12-18       Impact factor: 4.741

Review 3.  Recent topics in chemical and clinical research on glycated albumin.

Authors:  Yuki Ueda; Hideyuki Matsumoto
Journal:  J Diabetes Sci Technol       Date:  2015-01-21

4.  Serum albumin, but not glycated albumin was a potent factor affecting the performance of GFR equation based on serum creatinine.

Authors:  Masaru Horio; Enyu Imai; Yoshinari Yasuda; Tsuyoshi Watanabe; Hitoshi Yokoyama; Hirofumi Makino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2014-06-07       Impact factor: 2.801

5.  Usefulness of glycated albumin assay for diabetes monitoring.

Authors:  Randie R Little
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

6.  KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease.

Authors:  Vivian Fonseca; Takuji Kohzuma; Rodolfo J Galindo; Cyrus DeSouza
Journal:  Kidney Int       Date:  2021-12-11       Impact factor: 18.998

Review 7.  Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.

Authors:  Christina M Parrinello; Elizabeth Selvin
Journal:  Curr Diab Rep       Date:  2014       Impact factor: 4.810

Review 8.  Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus.

Authors:  Kunihiko Hashimoto; Masafumi Koga
Journal:  World J Diabetes       Date:  2015-07-25

9.  POTENTIAL ADVANTAGE OF REPAGLINIDE MONOTHERAPY IN GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES AND SEVERE RENAL IMPAIRMENT.

Authors:  K Mori; M Emoto; R Numaguchi; Y Yamazaki; H Urata; K Motoyama; T Morioka; T Shoji; M Inaba
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Apr-Jun       Impact factor: 0.877

10.  Visceral adiposity is associated with the discrepancy between glycated albumin and HbA1c in type 2 diabetes.

Authors:  Saori Maruo; Koka Motoyama; Tomoe Hirota; Yoshinori Kakutani; Yuko Yamazaki; Tomoaki Morioka; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Masanori Emoto
Journal:  Diabetol Int       Date:  2020-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.